Acute and chronic kidney injury during therapy for pediatric acute leukemia: A report from the Leukemia Electronic Abstraction of Records Network (LEARN)

Wendy Hsiao,Yimei Li,Kelly Getz,Lusha Cao,Edward Krause,Mark Ramos,Judy Lee,Maria Monica Gramatges,Karen R Rabin,Michael E Scheurer,Richard Aplenc,Michelle Denburg,Tamara P Miller
DOI: https://doi.org/10.1002/pbc.30696
Abstract:Children with acute leukemia are at increased risk of kidney injury. Using electronic health record data from three centers between 2010 and 2018, this study retrospectively described acute kidney injury (AKI) and chronic kidney disease (CKD) prevalence in children with acute lymphoblastic or myeloid leukemia (ALL, AML) using Common Terminology Criteria for Adverse Events (CTCAE) and Kidney Disease Improving Global Outcomes (KDIGO) definitions. AKI during therapy was 25% (ALL) and 32% (AML) using CTCAE, versus 84% (ALL) and 74% (AML) using KDIGO. CKD prevalence was low and Grade 1/Stage 2. Further investigation is needed to optimally define kidney injury in acute leukemia.
What problem does this paper attempt to address?